Project Description

David Happel Chrono Therapeutics

CEO: David Happel

Sector: Medtech, Drug delivery
Location: California, USA
Investment Stage: Early
Investment Status: Liquidated
Year Invested: 2016

Chrono Therapeutics

Chrono Therapeutics is dedicated to improving the lives of patients living with addictions and other neurological conditions by combining smart drug delivery, personalised behavioural support, data analytics, and improved compliance into one integrated product.

See Chrono Therapeutics related news here

Back to all companies

Endeavour Vision
Deal Team

Sven Lingjaerde

Sven Lingjaerde

Robert O'Holla

Robert O’Holla